Utility of Sodium Thiosulfate in Acute Cyanide Toxicity

2013 ◽  
Vol 61 (1) ◽  
pp. 124-125 ◽  
Author(s):  
Mae De La Calzada-Jeanlouie ◽  
Jaron Coombs ◽  
Nadia Shaukat ◽  
Dean Olsen
1997 ◽  
Vol 84 (5) ◽  
pp. 1121-1126 ◽  
Author(s):  
Steven C. Curry ◽  
Michael W. Carlton ◽  
Robert A. Raschke

2019 ◽  
Vol 74 (3) ◽  
pp. 423-429 ◽  
Author(s):  
Patrick C. Ng ◽  
Tara B. Hendry-Hofer ◽  
Alyssa E. Witeof ◽  
Sari B. Mahon ◽  
Matthew Brenner ◽  
...  

2008 ◽  
Vol 42 (11) ◽  
pp. 1600-1604 ◽  
Author(s):  
Brady Scott Moffett ◽  
Jack F Price

Background: Sodium nitroprusside (SNP) is often used in postoperative pediatric cardiac surgical patients. Cyanide toxicity may occur with the use of SNP. There is a paucity of literature describing dosing parameters or physical signs and symptoms of toxicity with SNP. Objective: To determine the incidence of cyanide toxicity in postoperative pediatric cardiac surgical patients treated with SNP and identify dosing parameters and physical signs and symptoms that may predict elevated cyanide concentrations. Methods: Medical records of patients who received SNP in the pediatric cardiac intensive care unit from January 2002 through December 2002 were identified and evaluated for cyanide and thiocyanate levels, dosing, and signs and symptoms of toxicity. Patients were included if they had received SNP after cardiac surgery, were 18 years of age or less, and had at least one cyanide or thiocyanate level determined while receiving therapy. Patients were excluded if they had received sodium thiosulfate. The Mann-Whitney U test was used to determine significant differences in mean dose, duration of infusion, renal function, serum lactate, and acid-base status between groups with elevated or nonelevated levels. Logistic regression and receiver operator curve were used to determine variables associated with elevated levels. Relationships between signs and symptoms of toxicity and elevated levels were evaluated with Fisher's exact test. Results: Cyanide concentrations were in the toxic range in 7 of 63 (11%) patients. Patients with elevated concentrations had significantly higher mean dose, cumulative dose, and acid-base excess values. Elevated cyanide levels were independently predicted by mean dose, cumulative dose, and acid-base excess values, and a dose of 1.8 μg/kg/min predicted an elevated cyanide concentration with 89% sensitivity and 88% specificity. Adverse events were not reliable predictors of elevated cyanide levels. Conclusions: Mean dose of SNP is the best predictor of elevated cyanide levels. Adverse events commonly associated with cyanide toxicity may not be reliable indicators of elevated cyanide concentrations.


1992 ◽  
Vol 26 (4) ◽  
pp. 515-519 ◽  
Author(s):  
Joseph P. Rindone ◽  
Edward P. Sloane

OBJECTIVE: To review the risks, manifestations, and treatment of cyanide toxicity from nitroprusside therapy. DATA SOURCES: All English case reports identified in Index Medicus (MEDLINE) of cyanide intoxication related to nitroprusside from 1970 to the present were reviewed. In addition, literature regarding the incidence, risks, and treatment of cyanide toxicity from nitroprusside is presented. CONCLUSIONS: Numerous cases of cyanide toxicity associated with nitroprusside have been reported. The overall incidence appears to be infrequent; however, certain patients may be at high risk. Risk factors may include hypoalbuminemia, cardiopulmonary bypass procedures, or the administration of moderate to high doses of nitroprusside. Treatment of cyanide toxicity requires the cessation of nitroprusside and, for severe toxicity, use of the cyanide antidote kit. Cyanide toxicity from nitroprusside may be prevented by concomitant administration of sodium thiosulfate infusions.


2010 ◽  
Vol 55 (4) ◽  
pp. 345-351 ◽  
Author(s):  
Vikhyat S. Bebarta ◽  
David A. Tanen ◽  
Julio Lairet ◽  
Patricia S. Dixon ◽  
Sandra Valtier ◽  
...  

2012 ◽  
Vol 59 (6) ◽  
pp. 532-539 ◽  
Author(s):  
Vikhyat S. Bebarta ◽  
Rebecca L. Pitotti ◽  
Patricia Dixon ◽  
Julio R. Lairet ◽  
Anneke Bush ◽  
...  

Author(s):  
Patrick C. Ng ◽  
Tara B. Hendry-Hofer ◽  
Matthew Brenner ◽  
Sari B. Mahon ◽  
Gerry R. Boss ◽  
...  

Author(s):  
Robyn Rufner ◽  
Gerhard W. Hacker ◽  
Michele Forte ◽  
Nancyleigh E. Carson ◽  
Cristina Xenachis ◽  
...  

The use of immunogold-silver staining (IGSS) to enhance label penetration and Localization for immunocytochemistry or in situ hybridization utilizing a variety of metallic salts has been documented. In this morphological study, the effects of silver acetate, silver lactate and silver nitrate were evaluated for immunogold-labeling of a trial natriuretic peptides (ANP) in rat right atria.Eight Wistar Kyoto retired breeders were sedated with pentobarbital, perfused with either 4% paraformaldehyde (LM) or Karnovsky's fixative (EM), and right atria were dissected, processed, embedded in paraffin or epon, respectively and sectioned according to conventional methods. For light microscopy, an indirect IGSS method according to Hacker (3) was performed. Paraffin sections on glass slides were washed in ddH2O, immersed in Lugol's iodine, washed in ddH2O and treated with 2.5% aqueous sodium thiosulfate for 20 sec. After additional washes in ddH2O and TBS-0.1% fish gelatin, 10% normal goat serum (PBS with 1% BSA) was applied for 20 min before an overnight incubation at 4°C with a polyclonal α-ANP primary antibody (Peninsula Labs, 1:1000 in TBS/BSA).


Sign in / Sign up

Export Citation Format

Share Document